跳至主要内容
临床试验/NL-OMON26072
NL-OMON26072招募中不适用

Additional treatment to primary PCI: effects of ischemic postconditioning after thrombectomy

Felix Zijlstra, MD, PhD and Olivier Manintveld, MD, PhD (Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands)0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
72

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients are included in the study when written informed consent is given. Consecutive patients as defined above are screened for inclusion in the trial. The eligibility criteria consist of the following:
  • 1. Delay between onset of chest pain and PCI ≤ 6 hours in case of inferiolateral wall infarction and ≤ 12 hours in case of anterior wall infarction;

排除标准

  • 1. Younger than 18 or older than 75 years of age;
  • 2. Cardiogenic shock defined as sustained systolic blood pressure ≤ 80 mmHg despite fluid hydration and/or the inability to discontinue vasopressors in less than 1 hour before;

研究者

发起方
Felix Zijlstra, MD, PhD and Olivier Manintveld, MD, PhD (Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands)

相似试验